Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-09-25
2007-09-25
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S249000, C514S365000, C514S469000, C514S621000, C544S059000, C544S356000, C548S200000, C549S468000, C564S169000
Reexamination Certificate
active
10070084
ABSTRACT:
The present invention includes benzophenone compounds (I)which are useful in the treatment of HIV infections.
REFERENCES:
patent: 4207234 (1980-06-01), Masashi et al.
patent: 4797415 (1989-01-01), Tomiyama et al.
patent: 4883815 (1989-11-01), Aschwenden et al.
patent: 5719143 (1998-02-01), Badorc et al.
patent: 5945450 (1999-08-01), Takenouchi et al.
patent: 0667344 (1995-02-01), None
patent: 1 552 793 (1969-01-01), None
patent: 198676 (1989-01-01), None
patent: 59 181246 (1984-10-01), None
patent: WO93/15043 (1993-05-01), None
patent: WO99 55682 (1999-11-01), None
Suarez et al., PubMed Abstract (Medicina (B Aries) 59(4):385:92), 1999.
Van Heeswijk, PubMed Abstract (Ther Drug Monit. 24(3):323-37), Jun. 2002.
Douglas Jr., Introductions to Viral Diseases, Cecil Textbook of Medicine, 20thEdtition, vol. 2, pp. 1739-1747, 1996.
Perron et al., CAOLD Abstract 55:5407f, 1960.
Brndl, CAPLUS Abstract 76:158266, 1972.
De Clercq, “Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection,” I1 Farmco, 1999, vol. 54, pp. 26-45.
Balzarini, “Suppression of Resistance to Drugs Targeted to Human Immunodeficiency Virus Reverse Transcriptase by Combination Therapy;” Biochemical-Pharmacology, 1999, vol. 58, p. 1.
Inaba, et al., “Benzodiazepines. V. A Novel Synthesis of a 7-Nitro-1, 4-benzodiazepine Derivative,” Chem. Pharm. Bull., 1971, vol. 19, p. 722.
Wyatt, PG., et al: Journal of Medicinal Chemistry, US, American Chemical Society. Washington, Journal Of Medicinal Chemistry, US, American Chemistry Society. Washington, vol. 38, No. 10, 1995, pp 1657-1665 XPOO2084134.
Sugasawa, T., et al: “1-Azacycloalkyl-1,4-benzodiazepin-2-ones with anxiety-antidepressant actions,” J. Med. Chem. (1985), 28(6), 699-707 XP002159556.
Capuano, L., et al: “Darstelling von alpha-'2-alkoxycarbonyl-anilino!-und alpha-'2-Acylanilino!-carbonsaureämiden” Justus Liebigs Ann. Chem. (1968), 712, 73-8 XP002159557.
Brandel, E.: “Penicillin reactions. 1. Behavior towards penicillinase” Sci. Pharm. (1971), 39(4), 267-92 XP000979965.
http://www.hivguidelines.org/public—html/center/clinical-education/q-and-a/hiv-2.htm, 2004.
http://www.aegis.com/aidsline/1992
ov/M92B0027.html, 1992.
European Search Report for 06075956.0 dated Aug. 11, 2006.
Andrews, III Clarence Webster
Chan Joseph Howing
Freeman George Andrew
Pianetti Pascal Maurice Charles
Romines Karen Rene
Parker Kimberly H.
Rao Deepak
SmithKline Beecham Corporation
LandOfFree
Benzophenones as inhibitors of reverse transcriptase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzophenones as inhibitors of reverse transcriptase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzophenones as inhibitors of reverse transcriptase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3800025